S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Race Oncology Limited (RAC.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: A$0.34
52-Week Range N/A
Volume76,322 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.


Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Phone61 3 9097 1656



Sales & Book Value

Annual Sales$159,371.00
Book ValueA$0.05 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive RAC News and Ratings via Email

Sign-up to receive the latest news and ratings for RAC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Race Oncology Limited (RAC.AX) (ASX:RAC) Frequently Asked Questions

What stocks does MarketBeat like better than Race Oncology Limited (RAC.AX)?

Wall Street analysts have given Race Oncology Limited (RAC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Race Oncology Limited (RAC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Race Oncology Limited (RAC.AX)'s earnings last quarter?

Race Oncology Limited (RAC.AX) (ASX:RAC) posted its earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share for the quarter.
View Race Oncology Limited (RAC.AX)'s earnings history

Who are some of Race Oncology Limited (RAC.AX)'s key competitors?

What other stocks do shareholders of Race Oncology Limited (RAC.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Race Oncology Limited (RAC.AX) investors own include Mesoblast (MESO), Pilbara Minerals Limited (PLS.AX) (PLS) and Mount Gibson Iron Limited (MGX.AX) (MGX).

Who are Race Oncology Limited (RAC.AX)'s key executives?

Race Oncology Limited (RAC.AX)'s management team includes the following people:
  • Mr. Phillip R. Lynch, CEO, MD & Director
  • Dr. Daniel Tillett, Chief Scientific Officer & Exec. Director
  • Prof. Borje S. Andersson, Chairman of Clinical Advisory Board & Chief Medical Officer
  • Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 58)

What is Race Oncology Limited (RAC.AX)'s stock symbol?

Race Oncology Limited (RAC.AX) trades on the ASX under the ticker symbol "RAC."

How big of a company is Race Oncology Limited (RAC.AX)?

Race Oncology Limited (RAC.AX) has a market capitalization of $0.00 and generates $159,371.00 in revenue each year.

What is Race Oncology Limited (RAC.AX)'s official website?

The official website for Race Oncology Limited (RAC.AX) is www.raceoncology.com.

How can I contact Race Oncology Limited (RAC.AX)?

The company can be reached via phone at 61 3 9097 1656.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.